A wide range of drugs can induce thrombocytopenia. Molecular mechanisms for
the formation of specific epitopes for all the drug-dependent antibodies a
ppear to be very similar A restricted set of glycoproteins an the platelet
surface interacts with the drugs to form neoepitopes, to which the drug-dep
endent antibodies bind. Molecular mapping of antigenic sites may help chara
cterize genetic polymorphisms that predispose to the formation of the antib
ody binding sites. Identification of antibody binding sites will enhance ou
r understanding of the pathogenesis of immune drug-induced thrombocytopenia
. Curr Opin Hematol 2001, 8:294-298 (C) 2001 Lippincott Williams & Wilkins,
Inc.